Specifications tableSubject areaBiologyMore specific subject areaProteomicsType of dataLC-MS/MS data and identification dataHow data was acquiredmaXis qTOF after the HDC-cell upgrade (Bruker, Germany) with a nano-electrospray source coupled to a Ultimate-3000 HPLC system (Thermo Scientific, USA).Data formatRaw and analyzed dataExperimental factors104 HPLC-MS/MS runs were performed: 65 samples for 43 isolates from 30 CD patients (17 male, 12 female, median age 30), 35 samples for 19 isolates from 7 healthy patients (7 male, median age 19), and 4 lab strains samples.Experimental features*E. coli* isolates collected from Crohn\'s disease patients and healthy individuals were cultivated on LB medium at aerobic conditions up to medium log phase and their total proteomes were analyzed by shotgun proteomics by HPLC-MS/MS.Data source locationResearch and Clinical Center of Physical-Chemical Medicine, Moscow, Russian FederationData accessibilityData was deposited to the PRIDE repository:\
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1. Data {#sec1}
=======

Escherichia coli is often observed as an abundant bacteria in intestines of Crohn\'s disease (CD) patients (Gevers et al., 2014) [@bib1], in cotrast with healthy individuals. To identify proteins expressed in *E. coli* isolates from CD patients and healthy individuals (listed in [Supplementary Table 1](#appsec3){ref-type="sec"}), we carried out HPLC-MS/MS proteome analysis of cultivated bacterial cells. Analyses were performed at maXis qTOF mass-spectrometer. Dataset covers 104 samples. Lists of identified proteins during search against three databases are given in [Supplementary Tables 2, 3 and 4](#appsec3){ref-type="sec"}. Proteins, significantly overrepresented in CD or healthy isolates identified are listed in [Supplementary table 5](#appsec3){ref-type="sec"}, and their functions are summarized in [Supplementary Table 6](#appsec3){ref-type="sec"} and [Table 1](#tbl1){ref-type="table"}. Numbers of proteins, significantly overrepresented in CD or healthy isolates, identified during search against three databases are given on [Fig. 1](#fig1){ref-type="fig"}. Principal component analysis (PCA) of *E. coli* proteomes with indication of patient\'s sex, isolate sources and diagnoses are given on [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}.Table 1Functions of proteins, significantly overrepresented in CD or healthy isolates of *E. coli* (Summary table of functions of overrepresented proteins that are found in at least one database). Functions and number of proteins involved in each function are listed for CD-enriched and healthy-enriched proteins.Table 1General functionsCD-overrepresentedhealthy-overrepresentedfunctionnumber of proteinsfunctionnumber of proteinsantibiotic resistanceantibiotic resistance2antibiotic and metall resistance3respiration/oxidationelectron transfer3energy homeostasis and in adenine nucleotide metabolism2anaerobic respiration1anaerobic respiration, response to DNA damage1cell redox homeostasis3cell redox homeostasis1Fe uptake2electron transfer6oxidoreductase5NAD(+) biosynthesis1NAD-oxidoreductase, DNA damage stress1Fe uptake3protoporphyrin-IX biosynthesis1metaboliccarbohydrate metabolism7alcohol metabolism7glycolytic process1Amino-sugar metabolism1glyoxylate and dicarboxylate metabolism.1ATP biosynthesis2indole production1carbohydrate metabolism22alcohol metabolism2ethanol biosynthetic process1lactate metabolism1fatty acids degradation1propanoate metabolism1glutathione biosynthesis1carbon utilization1glycolysis1molybdopterin biosynthesis1IMP biosynthesis via de novo pathway1mycothiol biosynthesis1isoprenoid biosynthetic process1phosphonate metabolism1polyol metabolism4pyruvate metabolism3Sulfur metabolism1teichoic acid biosynthesis1tricarboxylic acid cycle2capsule biosynthesisbiofilm formation1capsule biosynthesis1cell division1cell envelope, cell wall biogenesis6spore coat biogenesis1membrane biosynthesisfatty acids metabolism, biosynthesis1lipid biosynthesis1glycerolipid biosynthesis1lipopolysaccharide biosynthesis1lipid biosynthesis2glycerophospholipid metabolism1lipopolysaccharide biosynthesis2lipoprotein6lipoprotein biosynthesis1outer membrane protein3membrane proteinsflagellin1outer membrane transporter3outer membrane transporter6membrane protein1inner membrane protein3molybdate ion transport1antigen1quorum sensing1DNAcell division1DNA1DNA binding2DNA damage2purine metabolism/biosynthesis1DNA recombination4pyrimidine metabolism2DNA replication1purine metabolism/biosynthesis9pyrimidine metabolism/biosynthesis5nucleotide metabolism2nucleotide sugars metabolism2RNARNA degradation1transcription4transcription7tRNA biosynthesis4translation2ribosomal3protein processingpeptidase1peptidase4protein phosphorylation2protease2protein transport1protein dephosphorylation1proteolysis1protein folding1protein kinase1protein maturation3protein secretion1signal peptide processing1enzymes activity regulation1translationaa metabolism, biosynthesis, transport7aa biosynthesis23translation4aa catabolism1ribosomal31aa metabolism4tRNA biosynthesis5aa transport1cytosol protein2stress protectionchaperone2chaperone3stress protein8stress18Uncharacterized/hypothetical protein6Uncharacterized/hypothetical protein9vitamin, coenzyme, cofactorvitamin transport, oxidation1vitamin biosynthesis8coenzyme, cofactor biosynthesis4cofactor, coenzyme biosynthesis3virulencevirulence, host interaction protein2Fig. 1Number of common and unique proteins, significantly (p-value ≤ 0.05) overrepresented in Crohn\'s disease (CD) or healthy (H) isolates, identified during search against three databases.Fig. 1Fig. 2PCA clustering plot of proteins identified vs 16032015 database in proteomes of CD and healthy *E. coli* isolates. A, B, C, -- all proteins, D -- proteins significantly overrepresented in CD or healthy group. Various samples parameters are indicated. A -- patient\'s sex (black dots -- female, green -- male, red -- lab strains). B -- isolate source (black dots -- biopsy, blue -- lumen, red -- feces, green -- lab strains). C, D -- diagnosis (black dots -- CD, red -- healthy, green -- lab strains).Fig. 2Fig. 3PCA clustering plot of proteins identified vs LF82 database in proteomes of CD and healthy *E. coli* isolates. A, B, C, -- all proteins, D -- proteins significantly overrepresented in CD or healthy group. Various samples parameters are indicated. A -- patient\'s sex (black dots -- female, green -- male, red -- lab strains). B -- isolate source (black dots -- biopsy, blue -- lumen, red -- feces, green -- lab strains). C, D -- diagnosis (black dots -- CD, red -- healthy, green -- lab strains).Fig. 3Fig. 4PCA clustering plot of proteins identified vs Nissle 1917 database in proteomes of CD and healthy *E. coli* isolates. A, B, C, -- all proteins, D -- proteins significantly overrepresented in CD or healthy group. Various samples parameters are indicated. A -- patient\'s sex (black dots -- female, green -- male, red -- lab strains). B -- isolate source (black dots -- biopsy, blue -- lumen, red -- feces, green -- lab strains). C, D -- diagnosis (black dots -- CD, red -- healthy, green -- lab strains).Fig. 4

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Patients and samples {#sec2.1}
-------------------------

*Escherichia coli* isolates achieved from feces, ileum biopsy and liquid ileal content of Crohn\'s disease (CD) patients and ileal content and feces of healthy patients. Samples from CD patients were collected during diagnostic endoscopy at Central Scientific Institute of Gastroenterology (Moscow Clinical Research Centre, Moscow), State Scientific Center of Coloproctology (Ministry of Health of Russian Federation, Moscow) and Federal Research and Clinical Center of Physical-Chemical Medicine (Federal Medico-Biological Agency, Moscow). Duration of the disease was from four months to eight years. All patients had confirmed Crohn\'s disease three months before enrolment or earlier. The inclusion criteria were age above 18, endoscopically and radiologically diagnosed, and histologically confirmed Crohn\'s disease. The exclusion criteria were signs of indeterminate colitis, infectious diseases, anamnesis of total colectomy, presence of stoma, and recent antibiotic treatment.

Feces from healthy patients were collected in Clinical Center of Physical-Chemical Medicine (Federal Medico-Biological Agency, Moscow). Most material collections were performed in Moscow, however, some samples from CD patients were achieved by specialists of FRCCPCM during official visits to the hospitals in other regions of Russian Federation: Khabarovsk (2 patients), Syktyvkar (2 patients), Nizhny Novgorod (2 patients). Material collection was approved by local Ethics Committees, patients gave written informed consent for research and publication of data.

2.2. *E. coli* isolation and cultivation {#sec2.2}
----------------------------------------

Isolation of *E. coli* was as follows: liquid aspirates were diluted approximately ×10^6^ fold with sterile PBS. Approximately 0.05 ml volume of feces were placed into 0.5 ml of sterile PBS, vortexed to homogeneity, an aliquot was diluted approximately ×10^6^ fold. Biopsy samples were vortexed in 0.2 ml of sterile PBS. For all samples 0.1 ml of resulting liquid was spread onto LB agar plates. After overnight incubation on 37 °C, isolated colonies were identified as *Escherichia coli* on MALDI Mass-spectrometer Bruker Microflex with the MALDI Biotyper software (Bruker Daltonics, Germany) using the mass spectrometer Microflex LT (Bruker Daltonics, Germany).

Isolates were cultivated in LB at 37 °C (200 RPM) for 14 h. It was 3rd passage from the initial sample. Overnight cultures were diluted to 0.04 OD (540) and grown under the same conditions till mid-log phase (0.4 OD (540)). Bacterial cells were harvested by centrifugation (3500 g, 15 min) and pellet was washed twice with PBS.

2.3. Tryptic digestion of *E. coli* proteins {#sec2.3}
--------------------------------------------

Protein trypsinolysis was performed as described in (Matyushkina et al., 2016) [@bib2] with some alterations. Cell pellets were washed with PBS. Bacterial pellet was resuspended in 10 μl 100 mM NH4HCO3 with 0.5 mg/ml of lyzozyme and 1/10 volume of protease inhibitor mix. The suspension was incubated for 1 h at +4 °C. Then 10 μl of 10% of sodium deoxycholate (DCNa) and 1 μl nuclease mix (Promega) were added to the sample. The suspension was incubated for 1 h at +4 °C. Then the sample was diluted with 100 μl of 100 mM tris-HCl pH 8.0 with and 2.5mM EDTA. Cells were lyzed with ultrasonication for 1 min. Proteins were extracted with urea that was dissolved in each sample up to 6M concentration and incubated for 20 min at room temperature. After centrifugation for 10 min at 12 000 g, protein concentration was measured in supernatant by Bradford assay (Quick Start Bradford Protein Assay, BioRad) and samples were equalized.

The alcylation was performed as follows. 10 mM of reducing agent tris(2-carboxyethyl)phosphine (TCEP) was added and samples were incubated at 37 °C for 30 min. Then 30 mM of iodacetamide was added (IAA) and samples were kept at room temperature in the dark for 30 min. To avoid chemical modifications and remove the unreacted IAA, samples were treated with 5 mM TCEP and incubated for 20 min at RT. Protein hydrolysis was performed by trypsin (20 μg per sample, Trypsin Gold, Mass Spectrometry Grade, Promega) for 16 h at room temperature. After that samples were diluted with 6× volume of 100 mM tris-HCl pH 8.0 and protein hydrolysis was performed by addition of trypsin (in ratio trypsin : protein equal 1 : 50, Trypsin Gold, Mass Spectrometry Grade, Promega) in 0.1% SDS and incubation at 37 °C for 17h. At this point trypsinolysis stopped by addition of 10% TFA and incubation at 37 °C for 30 min. After centrifugation for 10 min at 12 000 g, supernatant was collected and cleaned with cartridges C18 (Discovery DSC-18 Tube, (Supelco)) according to the manufacturer\'s protocol. Achieved peptide extracts were dried at SpeedVac (Labconco) and dissolved in 15 μl of LC-MS-MS sample buffer containing 3% acetonitrile and 0.1% trifluoracetic acid. The equivalent of 5 μg of protein was loaded onto HPLC-MS/MS analysis.

2.4. HPLC-MS/MS analysis {#sec2.4}
------------------------

The HPLC-MS/MS analysis of the tryptic peptides was carried out using an Ultimate-3000 HPLC system (Thermo Scientific) coupled to a maXis qTOF after the HDC-cell upgrade (Bruker) with a nano-electrospray source. The chromatographic separation of the peptides was performed on a trap-elute system: trap column (Zorbax 300SB-C18, 5 mm × 0.3 mm, particle diameter 5 μm, Dionex) and column (Zorbax 300SB-C18, 150 mm × 75 μm, particle diameter 3.5 μm, Agilent). The gradient parameters were as follows: 5--35% acetonitrile in aqueous 0.1% (v/v) formic acid, the column flow 0.3 μl/min. The gradient duration was 120 min. The positive MS and MS/MS spectra were acquired using an AutoMSMS mode (the capillary voltage 1700, the curtain gas flow is 4 l and the temperature is 170 °C, the spectra rate 4 Hz, 20 precursors, m/z range 200--1500, the active exclusion after 2 spectra, release after 0.5 min). The lists of compounds (mgf files) were generated after a lock mass calibration (m/z 445.1200) with a Compass DataAnalysis (Bruker).

2.5. Protein identification and quantitative analysis {#sec2.5}
-----------------------------------------------------

The protein identification was performed by the peptide search with a Mascot Data Search with the following parameters: Peptide Mass Tolerance 0,05 Da, Fragment Mass Tolerance 0,1 Da, variable modifications Carbamidomethyl (C), Oxidation (M), cutting enzyme trypsin, 1 missed cleavage per peptide was allowed.

Peptide search for protein identification was performed versus database of proteins (peptides).

Databases for protein search by Mascot search were created as follows:

Ecoli-16032016-kerat.fasta - was created by translation and annotation by PROKKA 1.7 of 14 CD *E. coli* isolates and 12 isolates from healthy patients (summarized and described in Rakitina et al., 2017 [@bib3]). Similar proteins (\>80% homology at \>80% sequence) were united and the one showing maximum similarity with the other group members was used as representative. The database included: total sequences 92600, total residues 32006615. The cut-off ion score was \>28 as an indicator of identity (p-value \<0.05).

Nissle1917_goodProt_kerat.fasta -- was formed on the basis of genomes of genome of typical symbiotic *E. coli* strain).

Escherichia_coli_LF82_uid161965-1.fasta -- was formed on the basis of genomes of genome of typical CD *E. coli* strain).

Aminoacid sequences of trypsin (Promega) and Human keratins were added to all databases to avoid misinterpretation of contaminating proteins. The protein was considered as identified by no less than two unique peptides with the score above the threshold. Lists of identified proteins are given in [Supplementary Tables 2, 3 and 4](#appsec3){ref-type="sec"}.

The protein abundances were evaluated by a label-free method using an emPAI (Exponentially Modified Protein Abundance Index) determined by Mascot Data Search for each identified protein (Shinoda et al., 2010) [@bib4]. Proteins significantly overrepresented in CD or healthy group are listed in [Supplementary table 5](#appsec3){ref-type="sec"}. Numbers of proteins, significantly overrepresented in CD or healthy isolates, identified during search against three databases are given on [Fig. 1](#fig1){ref-type="fig"}.

2.6. Proteins abundance comparison between CD and healthy groups of *E. coli* isolates {#sec2.6}
--------------------------------------------------------------------------------------

The data of over- or under-represented proteins in CD and healthy groups of *E. coli* isolates, was achieved by the two-way Fisher test was used separately for each protein.

Principal component analysis (PCA) and T-distributed Stochastic Neighbor Embedding (T-SNE) analysis were used for data analysis. Principal components were constructed, representing orthogonal transformation of the analyzed data set. The principal component plot showed directions along which variation of data was maximum, so the 2d plot we can see the projection of distances among variables in multidimensional space. Variables in the 2d plot can group in clusters reflecting the correlation among variables like in clustering analysis. The test was performed in R with prcomp. T-SNE is a machine learning algorithm for visualization of high-dimensional data based on nonlinear dimensionality reduction. T-SNE analysis was performed in R with Rtsne.

Plotted 2D projections are given on [Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}. Patient\'s sex, isolate sources and diagnoses are indicated.
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